Actinium Pharmaceuticals, Inc.
Recent Filings
All 491 filings →| Form | Description | Date |
|---|---|---|
| 8-K/A | AMENDMENT NO.1 TO FORM 8-K | Mar 26, 2026 |
| 8-K | CURRENT REPORT | Feb 13, 2026 |
| 8-K | CURRENT REPORT | Nov 26, 2025 |
| 10-Q | QUARTERLY REPORT | Nov 14, 2025 |
| ARS | ARS | Nov 5, 2025 |
| DEF 14A | PROXY STATEMENT | Nov 5, 2025 |
| 4 | — | Aug 20, 2025 |
| 10-Q | QUARTERLY REPORT | Aug 8, 2025 |
| SCHEDULE 13G/A | — | Jul 29, 2025 |
| SCHEDULE 13G/A | — | Jul 16, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| SETH SANDESH | Chief Executive Officer | Award / Grant | 300,000 | 305,381 | Aug 17, 2022 |
| SETH SANDESH | Chairman & CEO | Purchase | 10,000 @ $0.44 | 153,333 | Dec 10, 2018 |
| O'Loughlin Steve | Principal Financial Officer | Purchase | 10,000 @ $0.44 | 35,500 | Dec 10, 2018 |
| Ludwig Dale L. | Chief Scientific Officer | Purchase | 10,000 @ $0.45 | 10,000 | Nov 19, 2018 |
| SETH SANDESH | CEO | Purchase | 10,000 @ $0.79 | 143,333 | Jul 17, 2018 |
| O'Loughlin Steve | Principal Financial Officer | Purchase | 12,000 @ $0.50 | 25,500 | Jun 15, 2018 |
| SETH SANDESH | Chairman & CEO | Purchase | 5,000 @ $0.38 | 133,333 | Apr 19, 2018 |
| Shetty Ajit | — | Purchase | 22,730 @ $0.43 | 22,730 | Feb 28, 2018 |
| SETH SANDESH | Chairman & CEO | Purchase | 33,333 @ $0.75 | 75,833 | Aug 2, 2017 |
| Ray Nitya G. | Executive Vice President | Purchase | 10,000 @ $0.75 | 10,000 | Aug 2, 2017 |